𝔖 Bobbio Scriptorium

✦ LIBER ✦

Guidelines for fracture healing assessments in clinical trials. Part I: Definitions and endpoint committees

✍ Scribed by Christopher Vannabouathong; Sheila Sprague; Mohit Bhandari

Book ID: 113661444
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 128 KB
Volume: 42
Category: Article
ISSN: 0020-1383
DOI: 10.1016/j.injury.2010.11.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guidelines for fracture healing assessme

Guidelines for fracture healing assessments in clinical trials. Part II: Electronic data capture and image management systems—Global Adjudicator™ system

✍ Natalie Kuurstra; Christopher Vannabouathong; Sheila Sprague; Mohit Bhandari 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Protocol of the Definition for the Asses

Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials

✍ Bellera, Carine A.; Pulido, Marina; Gourgou, Sophie; Collette, Laurence; Doussau 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 918 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB